American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Evogene Ltd. (EVGN)

$0.54 -0.04% NASDAQ: EVGN · 15-min delayed

Public · NASDAQ: EVGN
52 employees

Visit website Follow

$6.4MMarket cap

52Employees

EVGNNASDAQ

2008IPO

About Evogene Ltd.

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: EVGN
Employees: 52
IPO date: Mar 5, 2008
Industry: Industrial Supplies
Website: Visit site

Registry IDs

Ticker: EVGN Nasdaq
SEC CIK: 1574565
SIC: 2870 Agricultural Chemicals

Embed this company’s badge

Show Evogene Ltd.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/evogene-ltd/"><img src="https://americancompanies.com/badge/evogene-ltd.svg" alt="Evogene Ltd. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Evogene Ltd. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $6.4M

NASDAQ: EVGN

$0.54 -0.04%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.39 $1.49

52-week range

Market cap: $6.4M
Shares outstanding: 11.9M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Mar 5, 2008

Evogene Ltd. (EVGN) Stock Price

Trading 64% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Evogene Ltd..

Write a review

Newsroom

News about Evogene Ltd.

Plant Genotyping Equipment Market Size to Hit 1662.43 - GlobeNewswire GlobeNewswire Inc. · 2024-07-19 · positive Global Agricultural Biotechnology Market Size To Worth USD 268.32 Billion By 2033 | CAGR of 8.27% - GlobeNewswire GlobeNewswire Inc. · 2024-07-18 · neutral Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates Zacks Investment Research · 2024-03-07 Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates Zacks Investment Research · 2024-02-28 Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates Zacks Investment Research · 2024-02-26 Here's Why Evogene (EVGN) is a Great Momentum Stock to Buy Zacks Investment Research · 2024-01-12

News & sentiment via Polygon.io

FAQ

Evogene Ltd.: frequently asked questions

Is Evogene Ltd. an American company?

Evogene Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Evogene Ltd. publicly traded?

Yes — Evogene Ltd. is a publicly traded company. Its stock trades under the ticker symbol EVGN on the NASDAQ.

What does Evogene Ltd. do?

Evogene Ltd. is an American Industrial Supplies company in the Manufacturing & Industrial sector.

Explore